| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.05 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.09 | 0.05 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |